Research and Development
Our technology is at the heart of it all. It guides our pipeline and makes possible what was previously impossible.
We're designers and problem solvers by nature. Addressing unmet needs through novel but practical solutions is what drives our product pipeline.Examine the pipeline
Our technology platforms can lead to products that are easier to use for patients and caregivers, while reducing costs for payers and the healthcare system.Explore the technology
Xeris is developing its pipeline both through internal clinical development and external partnerships to advance the commercial potential of its products globally.Partner with us
Expanded Access Policy
Xeris recognizes that patients may seek access to medicines currently in our pipeline through Expanded Access. Our Expanded Access Policy is outlined here.View the policy
We are proud to announce that as of October 5, 2021,
Xeris Pharmaceuticals, Inc. and Strongbridge Biopharma plc
are subsidiaries of Xeris Biopharma Holdings, Inc.
Not opening? Check to see you have pop-ups enabled or copy link below in a new window.https://ir.xerispharma.com/